Clinical Trial Update: Nicotinic Receptor Density in Smoking and Nonsmoking Schizophrenics

View source ↗

Summary

A clinical trial studying nicotinic receptor density in smokers and non-smokers with schizophrenia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Schizophrenia | Status: WITHDRAWN